Pharmaceutical Supply – Benzonatate Capsules (100 MG)

This contract involves the supply of Benzonatate capsules at a 100 mg strength, provided in bottles containing 100 units each. The product must be FDA-approved and meet USP standards, ensuring quality and compliance with regulatory requirements. Additionally, the packaging must adhere to military specifications, reflecting the contract’s alignment with Department of Defense needs. Issued by the Medical Supply Chain Pharm FSA under the Department of Defense, this subcontract was posted on May 18, 2026, with a response deadline of May 26, 2026. It falls under the NAICS code 325412, which pertains to pharmaceutical manufacturing. While specific location details and points of contact are not provided, the procurement is aimed at supporting military pharmaceutical supply chains with essential medication meeting stringent quality and packaging criteria.